Product Overview:
Vaptor 5mg Tablets, manufactured by Searle, contain the active ingredient Rosuvastatin. This medication belongs to a class of drugs known as statins, which are used to lower cholesterol levels in the blood. Vaptor 5mg Tablets are commonly prescribed to treat high cholesterol and reduce the risk of heart disease and stroke.


Key Benefits:
- Lowers cholesterol levels
- Reduces the risk of heart disease and stroke
- Helps maintain a healthy heart
- Improves overall cardiovascular health
- Easy-to-take tablet form


How It Works:
Rosuvastatin works by blocking an enzyme in the liver that is responsible for producing cholesterol. By lowering the production of cholesterol, Vaptor 5mg Tablets help to reduce the amount of cholesterol in the blood, leading to improved heart health and reduced risk of cardiovascular diseases.


Directions for Use:
1. Take Vaptor 5mg Tablets as directed by your healthcare provider.
2. Swallow the tablet whole with a glass of water.
3. It can be taken with or without food, but it is recommended to take it at the same time each day.
4. Do not crush, chew, or break the tablet.


Precautions:
- Inform your doctor about any existing medical conditions or allergies before taking Vaptor 5mg Tablets.
- Avoid consuming grapefruit or grapefruit juice while taking this medication, as it may increase the risk of side effects.
- Do not take Vaptor 5mg Tablets if you are pregnant or breastfeeding, unless advised by your doctor.
- Monitor your cholesterol levels regularly to track the effectiveness of the medication.


Storage Instructions:
Store Vaptor 5mg Tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the tablets after the expiration date printed on the packaging.


Manufacturer Information:
Vaptor 5mg Tablets are manufactured by Searle, a trusted pharmaceutical company known for producing high-quality medications. Searle is committed to providing safe and effective healthcare solutions to improve the lives of patients worldwide.